For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

The Canadian market has been navigating a complex landscape in early 2026, marked by geopolitical shifts and economic data ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced an expansion of Cronos Growing Company (“GrowCo”).

Shares of Cronos Group (NASDAQ: CRON) have already more than doubled this year, according to data provided by S&P Global Market Intelligence. The Canadian cannabis producer is benefitting from a host ...

Shares of Cronos Group Inc. CRON slid 1.52% to $2.59 Thursday, on what proved to be an all-around great trading session for ...

Cronos Group Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.02. Operator: Good morning. My name is Stephen, and I will be your conference operator today. I ...

The Canadian cannabis purveyor saw a leap in revenue for its second quarter. This was largely, but not entirely, due to higher sales in its home market. For its second quarter, Cronos -- which reports ...

Shares of Cronos Group Inc. CRON slid 2.59% to $2.63 Wednesday, on what proved to be an all-around dismal trading session for ...

Cronos Group remains the strongest in its peer group, with robust international growth and an unmatched balance sheet. CRON is undervalued based on peer comparisons, showing the highest revenue growth ...